PW Medtech Group Ltd.PW Medtech Group Ltd.PW Medtech Group Ltd.

PW Medtech Group Ltd.

No trades
See on Supercharts
Market capitalization
‪216.14 M‬EUR
0.011EUR
‪20.32 M‬EUR
‪103.63 M‬EUR
‪395.67 M‬
Beta (1Y)
0.32
Employees (FY)
‪1.42 K‬
Change (1Y)
+171 +13.75%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About PW Medtech Group Ltd.


CEO
Yue E Zhang
Headquarters
Beijing
Founded
2011
ISIN
KYG7306W1087
FIGI
BBG005M0HDB4
PW Medtech Group Ltd. is an investment holding company, which engages in the manufacture and sale of infusion set products. It operates through the following segments: Infusion Set Business, Blood Purification Business, and Regenerative Medical Biomaterials Business. The Infusion Set Business segment represents the R&D, manufacturing and sales of advanced infusion set, intravenous cannula products, insulin needles. The Blood Purification Business segment represents the R&D, manufacturing and sales of hemodialysis and blood purification medical devices. The Regenerative Medical Biomaterials Business” segment represents the R&D and manufacturing of animal-derived tissue regenerative medical biomaterials and human tissue repair alternative product. The company was founded on May 13, 2011 and is headquartered in Beijing, China.

Check out other big names from the same industry as PWE.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange PW Medtech Group Ltd. stocks are traded under the ticker PWE.
PWE reached its all-time high on Oct 29, 2014 with the price of 0.486 EUR, and its all-time low was 0.042 EUR and was reached on May 17, 2023. View more price dynamics on PWE chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track PW Medtech Group Ltd. financials in yearly and quarterly reports right on TradingView.
PWE net income for the last half-year is ‪7.66 M‬ EUR, while the previous report showed ‪10.86 M‬ EUR of net income which accounts for −29.45% change. Track more PW Medtech Group Ltd. financial stats to get the full picture.
PW Medtech Group Ltd. dividend yield was 9.80% in 2024, and payout ratio reached 92.54%. The year before the numbers were 12.01% and 91.12% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 9, 2025, the company has ‪1.42 K‬ employees. See our rating of the largest employees — is PW Medtech Group Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PW Medtech Group Ltd. EBITDA is ‪31.35 M‬ EUR, and current EBITDA margin is 32.70%. See more stats in PW Medtech Group Ltd. financial statements.
Like other stocks, PWE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PW Medtech Group Ltd. stock right from TradingView charts — choose your broker and connect to your account.